September 16, 2026
Authored and Edited by Jillian M. Baggett; Christopher B. Anderson; Sonja W. Sahlsten
In Socket Solutions, LLC v. Import Global, LLC, No. 2025-1121 (Fed. Cir. Aug. 4, 2026), the Federal Circuit vacated a preliminary injunction against defendant Import Global’s Neat Socket® electrical outlet cover product, holding that the district court erred in its claim construction analysis.
Socket Solutions sued Import Global, alleging that the accused product infringed its patent directed to an outlet cover apparatus that permits use of a wall outlet while concealing the outlet contact openings. Adopting the magistrate judge’s claim-construction recommendations, the district court issued a preliminary injunction enjoining Import Global from selling the accused product.
On appeal, the Federal Circuit vacated the preliminary injunction, finding that the district court’s likelihood-of-success analysis relied on erroneous constructions of the terms “backplate” and “pin.” As to the backplate term, the Federal Circuit rejected the district court’s construction that imposed an unsupported negative limitation regarding its location. Regarding the pin term, the Federal Circuit held that there was no basis in the record to depart from the plain and ordinary meaning of the term, and that a purely functional description would be overly broad. The Court further held that the district court erred to the extent that it applied a presumption of irreparable harm.
Copyright © Finnegan, Henderson, Farabow, Garrett & Dunner, LLP.
DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.
Conference
2nd Annual Forum on Pharma & Biotech Patent Litigation USA & Canada
October 14-16, 2026
New York
At the PTAB Blog
The Proof Is in the Priority: Director Squires Addresses Antedating and Prior-Art Qualification
September 14, 2026
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.